Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis
Horst Olschewski(Sigmund Freud Privatuniversität Wien), Werner Seeger(Justus-Liebig-Universität Gießen), Bettina Temmesfeld‐Wollbrück, Hossein Ardeschir Ghofrani(Justus-Liebig-Universität Gießen), Friedrich Grimminger(Justus-Liebig-Universität Gießen), D. Walmrath(Justus-Liebig-Universität Gießen), Ralph T. Schermuly(Justus-Liebig-Universität Gießen)
American Journal of Respiratory and Critical Care Medicine
August 1, 1999
Cited by 410
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Clinical classification of pulmonary hypertension
|Journal of the American College of Cardiology|2004|1.9k
Inhaled Iloprost for Severe Pulmonary Hypertension
|New England Journal of Medicine|2002|1.8k
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Reversal of experimental pulmonary hypertension by PDGF inhibition
|Journal of Clinical Investigation|2005|1.1k